PBS Datasets
Collection
A collection of datasets from the Australian Pharmaceutical Benefits Scheme (PBS). Updated with a new schedule on the 1st of every month.
•
32 items
•
Updated
Dataset Viewer
atc_code
stringlengths 1
7
| atc_description
stringlengths 3
113
| atc_level
int64 1
5
| atc_parent_code
stringlengths 1
5
⌀ | schedule_code
int64 3.67k
3.67k
|
|---|---|---|---|---|
A | ALIMENTARY TRACT AND METABOLISM | 1 | null | 3,671 |
A00 | ALIMENTARY TRACT AND METABOLISM | 2 | A | 3,671 |
A01 | STOMATOLOGICAL PREPARATIONS | 2 | A | 3,671 |
A01A | STOMATOLOGICAL PREPARATIONS | 3 | A01 | 3,671 |
A01AA | Caries prophylactic agents | 4 | A01A | 3,671 |
A01AA01 | sodium fluoride | 5 | A01AA | 3,671 |
A01AA02 | sodium monofluorophosphate | 5 | A01AA | 3,671 |
A01AA03 | olaflur | 5 | A01AA | 3,671 |
A01AA04 | stannous fluoride | 5 | A01AA | 3,671 |
A01AA30 | combinations | 5 | A01AA | 3,671 |
A01AA51 | sodium fluoride, combinations | 5 | A01AA | 3,671 |
A01AB | Antiinfectives and antiseptics for local oral treatment | 4 | A01A | 3,671 |
A01AB02 | hydrogen peroxide | 5 | A01AB | 3,671 |
A01AB03 | chlorhexidine | 5 | A01AB | 3,671 |
A01AB04 | amphotericin B | 5 | A01AB | 3,671 |
A01AB05 | polynoxylin | 5 | A01AB | 3,671 |
A01AB06 | domiphen | 5 | A01AB | 3,671 |
A01AB07 | oxyquinoline | 5 | A01AB | 3,671 |
A01AB08 | neomycin | 5 | A01AB | 3,671 |
A01AB09 | miconazole | 5 | A01AB | 3,671 |
A01AB10 | natamycin | 5 | A01AB | 3,671 |
A01AB11 | various | 5 | A01AB | 3,671 |
A01AB12 | hexetidine | 5 | A01AB | 3,671 |
A01AB13 | tetracycline | 5 | A01AB | 3,671 |
A01AB14 | benzoxonium chloride | 5 | A01AB | 3,671 |
A01AB15 | tibezonium iodide | 5 | A01AB | 3,671 |
A01AB16 | mepartricin | 5 | A01AB | 3,671 |
A01AB17 | metronidazole | 5 | A01AB | 3,671 |
A01AB18 | clotrimazole | 5 | A01AB | 3,671 |
A01AB19 | sodium perborate | 5 | A01AB | 3,671 |
A01AB21 | chlortetracycline | 5 | A01AB | 3,671 |
A01AB22 | doxycycline | 5 | A01AB | 3,671 |
A01AB23 | minocycline | 5 | A01AB | 3,671 |
A01AB24 | octenidine | 5 | A01AB | 3,671 |
A01AB25 | oxytetracycline | 5 | A01AB | 3,671 |
A01AB53 | chlorhexidine and cetylpyridinium | 5 | A01AB | 3,671 |
A01AC | Corticosteroids for local oral treatment | 4 | A01A | 3,671 |
A01AC01 | triamcinolone | 5 | A01AC | 3,671 |
A01AC02 | dexamethasone | 5 | A01AC | 3,671 |
A01AC03 | hydrocortisone | 5 | A01AC | 3,671 |
A01AC04 | prednisolone | 5 | A01AC | 3,671 |
A01AC54 | prednisolone, combinations | 5 | A01AC | 3,671 |
A01AD | Other agents for local oral treatment | 4 | A01A | 3,671 |
A01AD01 | epinephrine | 5 | A01AD | 3,671 |
A01AD02 | benzydamine | 5 | A01AD | 3,671 |
A01AD05 | acetylsalicylic acid | 5 | A01AD | 3,671 |
A01AD06 | adrenalone | 5 | A01AD | 3,671 |
A01AD07 | amlexanox | 5 | A01AD | 3,671 |
A01AD08 | becaplermin | 5 | A01AD | 3,671 |
A01AD11 | various | 5 | A01AD | 3,671 |
A02 | DRUGS FOR ACID RELATED DISORDERS | 2 | A | 3,671 |
A02A | ANTACIDS | 3 | A02 | 3,671 |
A02AA | Magnesium compounds | 4 | A02A | 3,671 |
A02AA01 | magnesium carbonate | 5 | A02AA | 3,671 |
A02AA02 | magnesium oxide | 5 | A02AA | 3,671 |
A02AA03 | magnesium peroxide | 5 | A02AA | 3,671 |
A02AA04 | magnesium hydroxide | 5 | A02AA | 3,671 |
A02AA05 | magnesium silicate | 5 | A02AA | 3,671 |
A02AA10 | combinations | 5 | A02AA | 3,671 |
A02AB | Aluminium compounds | 4 | A02A | 3,671 |
A02AB01 | aluminium hydroxide | 5 | A02AB | 3,671 |
A02AB02 | algeldrate | 5 | A02AB | 3,671 |
A02AB03 | aluminium phosphate | 5 | A02AB | 3,671 |
A02AB04 | dihydroxialumini sodium carbonate | 5 | A02AB | 3,671 |
A02AB05 | aluminium acetoacetate | 5 | A02AB | 3,671 |
A02AB06 | aloglutamol | 5 | A02AB | 3,671 |
A02AB07 | aluminium glycinate | 5 | A02AB | 3,671 |
A02AB10 | combinations | 5 | A02AB | 3,671 |
A02AC | Calcium compounds | 4 | A02A | 3,671 |
A02AC01 | calcium carbonate | 5 | A02AC | 3,671 |
A02AC02 | calcium silicate | 5 | A02AC | 3,671 |
A02AC10 | combinations | 5 | A02AC | 3,671 |
A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | 4 | A02A | 3,671 |
A02AD01 | ordinary salt combinations | 5 | A02AD | 3,671 |
A02AD02 | magaldrate | 5 | A02AD | 3,671 |
A02AD03 | almagate | 5 | A02AD | 3,671 |
A02AD04 | hydrotalcite | 5 | A02AD | 3,671 |
A02AD05 | almasilate | 5 | A02AD | 3,671 |
A02AF | Antacids with antiflatulents | 4 | A02A | 3,671 |
A02AF01 | magaldrate and antiflatulents | 5 | A02AF | 3,671 |
A02AF02 | ordinary salt combinations and antiflatulents | 5 | A02AF | 3,671 |
A02AG | Antacids with antispasmodics | 4 | A02A | 3,671 |
A02AH | Antacids with sodium bicarbonate | 4 | A02A | 3,671 |
A02AX | Antacids, other combinations | 4 | A02A | 3,671 |
A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | 3 | A02 | 3,671 |
A02BA | H2-receptor antagonists | 4 | A02B | 3,671 |
A02BA01 | cimetidine | 5 | A02BA | 3,671 |
A02BA02 | ranitidine | 5 | A02BA | 3,671 |
A02BA03 | famotidine | 5 | A02BA | 3,671 |
A02BA04 | nizatidine | 5 | A02BA | 3,671 |
A02BA05 | niperotidine | 5 | A02BA | 3,671 |
A02BA06 | roxatidine | 5 | A02BA | 3,671 |
A02BA07 | ranitidine bismuth citrate | 5 | A02BA | 3,671 |
A02BA08 | lafutidine | 5 | A02BA | 3,671 |
A02BA51 | cimetidine, combinations | 5 | A02BA | 3,671 |
A02BA53 | famotidine, combinations | 5 | A02BA | 3,671 |
A02BB | Prostaglandins | 4 | A02B | 3,671 |
A02BB01 | misoprostol | 5 | A02BB | 3,671 |
A02BB02 | enprostil | 5 | A02BB | 3,671 |
A02BC | Proton pump inhibitors | 4 | A02B | 3,671 |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 98
Size of downloaded dataset files:
325 kB
Size of the auto-converted Parquet files:
325 kB
Number of rows:
15,576